To evaluate the clinical efficacy and safety of the Shufeng Huashi (SFHS) formula in patients with post-infectious cough (PIC), addressing the limitations of current treatments.
Key Findings:
Post-infectious cough is common and significantly impacts quality of life, with specific data on prevalence.
Current pharmacological treatments for PIC have limited efficacy and side effects, supported by references.
Traditional Chinese Medicine (TCM) may offer effective alternatives with fewer side effects, with examples of TCM efficacy.
Interpretation:
The trial aims to provide evidence on the efficacy and safety of TCM in treating PIC, potentially informing clinical practice and guiding future research.
Limitations:
The study is limited to a specific age group (18-65 years), which may affect generalizability.
Results may not be generalizable beyond the study population and settings, with potential biases or confounding factors considered.
Conclusion:
The study seeks to validate the SFHS formula as a therapeutic option for PIC, addressing the need for effective treatments and its implications for clinical practice.
